These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7581269)

  • 1. Pathogenesis of Rhodococcus equi infection in mice: roles of virulence plasmids and granulomagenic activity of bacteria.
    Takai S; Madarame H; Matsumoto C; Inoue M; Sasaki Y; Hasegawa Y; Tsubaki S; Nakane A
    FEMS Immunol Med Microbiol; 1995 Jun; 11(3):181-90. PubMed ID: 7581269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulent and avirulent Rhodococcus equi infection in T-cell deficient athymic nude mice: pathologic, bacteriologic and immunologic responses.
    Madarame H; Takai S; Matsumoto C; Minamiyama K; Sasaki Y; Tsubaki S; Hasegawa Y; Nakane A
    FEMS Immunol Med Microbiol; 1997 Apr; 17(4):251-62. PubMed ID: 9143883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live virulent Rhodococcus equi, rather than killed or avirulent, elicits protective immunity to R. equi infection in mice.
    Takai S; Kobayashi C; Murakami K; Sasaki Y; Tsubaki S
    FEMS Immunol Med Microbiol; 1999 May; 24(1):1-9. PubMed ID: 10340706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse lung infection model to assess Rhodococcus equi virulence and vaccine protection.
    González-Iglesias P; Scortti M; MacArthur I; Hapeshi A; Rodriguez H; Prescott JF; Vazquez-Boland JA
    Vet Microbiol; 2014 Aug; 172(1-2):256-64. PubMed ID: 24852140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity and virulence of Rhodococcus equi in foals following intratracheal challenge.
    Wada R; Kamada M; Anzai T; Nakanishi A; Kanemaru T; Takai S; Tsubaki S
    Vet Microbiol; 1997 Jun; 56(3-4):301-12. PubMed ID: 9226844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth temperature on maintenance of virulent Rhodococcus equi.
    Takai S; Sugawara T; Watanabe Y; Sasaki Y; Tsubaki S; Sekizaki T
    Vet Microbiol; 1994 Mar; 39(1-2):187-92. PubMed ID: 8203124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi.
    Takai S; Sekizaki T; Ozawa T; Sugawara T; Watanabe Y; Tsubaki S
    Infect Immun; 1991 Nov; 59(11):4056-60. PubMed ID: 1937765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice.
    Prescott JF; Patterson MC; Nicholson VM; Morein B; Yager JA
    Vet Microbiol; 1997 Jun; 56(3-4):213-25. PubMed ID: 9226836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi.
    Kasuga-Aoki H; Takai S; Sasaki Y; Tsubaki S; Madarame H; Nakane A
    Immunology; 1999 Jan; 96(1):122-7. PubMed ID: 10233686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence of Rhodococcus equi isolates from patients with and without AIDS.
    Takai S; Sasaki Y; Ikeda T; Uchida Y; Tsubaki S; Sekizaki T
    J Clin Microbiol; 1994 Feb; 32(2):457-60. PubMed ID: 8150957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence-associated plasmids in Rhodococcus equi.
    Takai S; Watanabe Y; Ikeda T; Ozawa T; Matsukura S; Tamada Y; Tsubaki S; Sekizaki T
    J Clin Microbiol; 1993 Jul; 31(7):1726-9. PubMed ID: 8349748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of virulence-associated antigens and plasmids in Rhodococcus equi from patients with AIDS.
    Takai S; Imai Y; Fukunaga N; Uchida Y; Kamisawa K; Sasaki Y; Tsubaki S; Sekizaki T
    J Infect Dis; 1995 Nov; 172(5):1306-11. PubMed ID: 7594668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
    Haghighi HR; Prescott JF
    Vet Immunol Immunopathol; 2005 Apr; 104(3-4):215-25. PubMed ID: 15734542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
    Cardoso SA; Oliveira AF; Ruas LP; Trevisani MM; De Oliveira LL; Hanna ES; Roque-Barreira MC; Soares SG
    Vaccine; 2013 Sep; 31(41):4528-35. PubMed ID: 23933366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody specific to virulence-associated 15- to 17-kilodalton antigens of Rhodococcus equi.
    Takai S; Iie M; Kobayashi C; Morishita T; Nishio T; Ishida T; Fujimura T; Sasaki Y; Tsubaki S
    J Clin Microbiol; 1993 Oct; 31(10):2780-2. PubMed ID: 8253982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to the Rhodococcus equi infection in high and low antibody-producing mice (Selection IV-A).
    Pedrini SC; Acorci MJ; Pinto JG; Silveira LV; Oliveira SL
    Microbiol Immunol; 2005; 49(10):915-23. PubMed ID: 16237269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhodococcus equi Infections in Goats: Characterization of Virulence Plasmids.
    Stranahan LW; Plumlee QD; Lawhon SD; Cohen ND; Bryan LK
    Vet Pathol; 2018 Mar; 55(2):273-276. PubMed ID: 29254455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.
    Vanniasinkam T; Barton MD; Heuzenroeder MW
    Int J Med Microbiol; 2005 Jan; 294(7):437-45. PubMed ID: 15715172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of an intracellular avirulent Rhodococcus equi replication defect by the extracellular addition of virulence-associated protein A.
    Sangkanjanavanich N; Kawai M; Kakuda T; Takai S
    J Vet Med Sci; 2017 Aug; 79(8):1323-1326. PubMed ID: 28690290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice.
    Phumoonna T; Barton MD; Vanniasinkam T; Heuzenroeder MW
    Vaccine; 2008 May; 26(20):2457-65. PubMed ID: 18423949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.